HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA Warns CARB On Listing Antimicrobials, Astringents In VOC Regs

This article was originally published in The Rose Sheet

Executive Summary

The California Air Resources Board should be careful to avoid potential conflicts with FDA OTC antimicrobial and astringent monographs when including such products in a draft list of categories proposed for volatile organic compound regulations, according to the Cosmetic, Toiletry and Fragrance Association

You may also be interested in...



CARB Urged By Industry To Postpone November Board Hearing

The California Air Resources Board should postpone its Nov. 16 board hearing in order to give industries time to better prepare for volatile organic compound emissions regulations, according to the Cosmetic, Toiletry and Fragrance Association

CARB Urged By Industry To Postpone November Board Hearing

The California Air Resources Board should postpone its Nov. 16 board hearing in order to give industries time to better prepare for volatile organic compound emissions regulations, according to the Cosmetic, Toiletry and Fragrance Association

VOC Reactivity Standards For Hair Spray Weighed During CARB Meeting

A California Air Resources Board proposal to set a limit on the reactivity of volatile organic compounds in hair spray in addition to the existing mass-based VOC limit was debated during a June 1 Consumer Products Regulation Workgroup Meeting

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013825

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel